Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
INFANTS IBUPROFEN (Ibuprofen)
Safeway · suspension/ drops · NDC 21130-513
INFANTS IBUPROFEN is an over-the-counter medicine made available by Safeway, on the U.S. market since June 2025. It is marketed under an FDA approval (ANDA ANDA075217), so the FDA has reviewed its safety, effectiveness and manufacturing. A listing proves the product exists; it does not prove that a particular pack is genuine, so compare yours with the official description below.
What the genuine product looks like
From the official FDA label (version of Jul 21, 2025). Compare the colour, shape, imprint and packaging with what you have. Any difference is a reason to ask a pharmacist before taking it.
Product data on the label: INFANTS IBUPROFEN Ibuprofen IBUPROFEN IBUPROFEN ANHYDROUS CITRIC ACID GLYCERIN HYPROMELLOSE, UNSPECIFIED POLYSORBATE 80 WATER SODIUM BENZOATE SORBITOL SOLUTION SUCROSE XANTHAN GUM Opaque mixed
Text on the package panel: Principal Display Panel COMPARE TO Motrin® Infants’ Drops active ingredient Signature SELECT™ For Ages 6 Mos. to 23 Mos. Infants’ Ibuprofen Oral Suspension 50 mg per 1.25 mL Pain Reliever/Fever Reducer (NSAID) BERRY FLAVOR LOVE IT OR IT’S ON US CONCENTRATED DROPS Non-Staining Dye-Free Gluten-Free No High Fructose Corn Syrup LASTS UP TO 8 HOURS 1 FL OZ (30 mL) USE ONLY WITH ENCLOSED SYRINGE signature-select-infants-ibuprofen-berry-carton-image.jpg
What it is for
Purposes Pain reliever/fever reducer
Key warnings
Warnings Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: • hives • facial swelling • asthma (wheezing) • shock • skin reddening • rash • blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if your child: • has had stomach ulcers or bleeding problems • takes a blood thinning (anticoagulant) or steroid drug • takes other drugs containing prescription or nonprescriptio…
Excerpts from the FDA label. Always read the leaflet in your pack and ask a pharmacist or doctor about your own situation.
Recalls of this product
No FDA recalls are recorded for NDC 21130-513. Recalls are listed in FDA enforcement reports from 2004 onward.
Other recent recalls of ibuprofen
Same active ingredient, other companies or packs. Check the company and lot number on your pack.
CGMP Deviations
Failed Tablet/Capsule Specifications
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
cGMP deviations: Temperature abuse
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Show as table
| Item | Value (reports) |
|---|---|
| Drug ineffective | 27,695 |
| Pain | 19,683 |
| Fatigue | 19,020 |
| Nausea | 18,574 |
| Headache | 16,765 |
| Arthralgia | 13,653 |
| Dyspnoea | 13,294 |
| Vomiting | 13,218 |
| Diarrhoea | 12,905 |
| Dizziness | 11,570 |
These counts are reports, not proof that the medicine caused the problem. Popular medicines get more reports simply because more people take them. They are useful for spotting what to watch for, not for comparing medicines.
Official listing
Active ingredients
Packages (1)
The last part of the NDC identifies the pack size. Your box should show one of these.
Think your pack is fake?
Stop taking it, keep the pack and receipt, and show it to a pharmacist. In the U.S., report it to FDA MedWatch; elsewhere, to your national medicines regulator. How to spot a fake medicine.
Source: openFDA (U.S. Food and Drug Administration) drug directory, labels, enforcement reports and FAERS, retrieved Nov 9, 2026. The FDA notes this data should not be relied on alone for medical decisions. Not medical advice.